Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3- dihydroindol-2-ones

Journal of Medicinal Chemistry

Volumn 49, Issue 23, 2006, Pages 6922-6924

  Andreani, Aldo ^a   Burnelli, Silvia ^a   Granaiola, Massimiliano ^a   Leoni, Alberto ^a   Locatelli, Alessandra ^a   Morigi, Rita ^a   Rambaldi, Mirella ^a   Varoli, Lucilla ^a   Kunkel, Mark W ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3,4,5 TRIMETHOXYBENZYLIDENE) 1,3 DIHYDROINDOL 2 ONE DERIVATIVE; ANTINEOPLASTIC AGENT; BENZYLIDENE DERIVATIVE; COLCHICINE; COMBRETASTATIN A4; PODOPHYLLOTOXIN; UNCLASSIFIED DRUG;

ALGORITHM; ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CORRELATION ANALYSIS; DRUG DESIGN; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HEALTH CARE ORGANIZATION; HUMAN; HUMAN CELL; REVIEW;

ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INDOLES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33750986811     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0607808     Document Type: Review

References (16)

1. This is part 39 in the series on potential antitumor agents. For part 38, see ref 5.
2. Andreani, A.; Rambaldi, M.; Locatelli, A.; Bossa, R.; Galatulas, I.; Ninci, M. Synthesis and Cardiotonic Activity of 2-Indolinones. Eur. J. Med. Chem. 1990, 25, 187-190.
3. Andreani, A.; Rambaldi, M.; Locatelli, A.; Bongini, A.; Bossa, R.; Galatulas, I.; Ninci, M. Synthesis and Cardiotonic Activity of Pyridylmethylene-2-indolinones. Eur. J. Med. Chem. 1992, 27, 167-170.
4. Andreani, A.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Garaliene, V.; Farruggia, G.; Masotti, L. Substituted E-3-(2-Chloro-3-indolylmethylene) 1,3-dihydroindol-2-ones with Antitumor Activity. Bioorg. Med. Chem. 2004, 12, 1121-1128.
5. Andreani, A.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Garaliene, V.; Welsh, W.; Arora, S.; Farruggia, G.; Masotti, L. Antitumor Activity of New Substituted 3-(5-Imidazo-[2,1-b]thiazolylmethylene)-2- indolinones and Study of Their Effect on the Cell Cycle. J. Med. Chem. 2005, 48, 5604-5607.
6. Walker, G. N.; Smith, R. T.; Weaver, B. N. Synthesis of New 3-(Pyridylmethylene)-, 3-(Pyridylmethyl)-, 3-(Piperidylmethyl)-, and 3-(β-Alkylaminoethyl)-2-indolinones. The Reduction of Isoindogenides, Nitro Compounds, and Pyridines in a Series of 2-indolinones. J. Med. Chem. 1965, 8, 626-637.
7. Rapoport, H.; Allen, R. H.; Cisney, M. E. The Synthesis of Isocolchinol Methyl Ether. J. Am. Chem. Soc. 1955, 77, 670-675.
8. Bouerat, L. M. E.; Fensholdt, J.; Nielsen, S. F.; Liang, X.; Havez, S. E.; Andersson, E. C.; Jensen, L.; Hansen, J. R. Preparation of Indolinone Derivatives as Agents to Prevent, Treat and/or Ameliorate Multiple Sclerosis. PCT Int. Appl. WO 2005058309, 2005.
9. Li, P.-K.; Xiao, Z.; Hu, Z.; Pandit, B.; Sun, Y.; Sackett, D. L.; Werbovetz, K.; Lewis, A.; Johnsamuel, J. Conformationally Restricted Analogs of Combretastatin A-4 Derived from SU5416. Bioorg. Med. Chem. Lett. 2005, 15, 5382-5385.
10. Tron, G. C.; Pirali, T.; Sorba, G.; Pagliai, F.; Busacca, S.; Genazzani, A. A. Medicinal Chemistry of Combretastatin A4: Present and Future Directions. J. Med. Chem. 2006, 49, 3033-3044.
11. Paull, K. D.; Shoemaker, R. H.; Hodes, L.; Monks, A.; Scudiero, D. A.; Rubinstein, L.; Plowman, J.; Boyd, M. R. Display and Analysis of Patterns of Differential Activity of Drugs against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm. J. Natl. Cancer Inst. 1989, 81, 1088-1092.
12. Andreani, A.; Locatelli, A.; Rambaldi, M.; Leoni, A.; Bossa, R.; Fraccari, A.; Galatulas, I. Potential Antitumor Agents. 25. Synthesis and Cytotoxic Activity of 3-(2-Chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones. Anticancer Res. 1996, 16, 3585-3588.
13. Sosinski, J.; Thakar, J. H.; Germain, G. S.; Harwood, F. C.; Houghton, P. J. Proliferation-Dependent and -Independent Cytotoxicity by Antitumor Diarylsulfonylureas. Indication of Multiple Mechanisms of Drug Action. Biochem. Pharmacol. 1993, 45, 2135-2142.
14. Xiang, X.; Saha, A. K.; Wen, R.; Ruderman, N. B.; Luo, Z. AMP-Activated Protein Kinase Activators Can Inhibit the Growth of Prostate Cancer Cells by Multiple Mechanisms. Biochem. Biophys. Res. Commun. 2004, 321, 161-167.
15. Brahimi, F.; Rachid, Z.; Qiu, Q.; McNamee, J. P.; Li, Y. J.; Tari, A. M.; Jean-Claude, B. J. Multiple Mechanisms of Action of ZR2002 in Human Breast Cancer Cells: A Novel Combi-molecule Designed To Block Signaling Mediated by the ERB Family of Oncogenes and To Damage Genomic DNA. Int. J. Cancer 2004, 112, 484-491.
16. Haidara, K.; Zamir, L.; Shi, Q. W.; Batist, G. The Flavonoid Casticin Has Multiple Mechanisms of Tumor Cytotoxicity Action. Cancer Lett. 2006, 242, 180-190.